FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely, to experimental pharmacology. Method includes introduction of actoprotective preparation reamberinum intravenously in doze of 10 mg/kg of animal weight in morning hours 40 minutes before carrying out Porsolt tests and tests of vertical screen-net.
EFFECT: extending arsenal of means for enhancing work capacity of laboratory animals in experiment.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ENHANCING LEVEL OF WORK CAPACITY OF LABORATORY ANIMALS IN EXPERIMENT | 2016 |
|
RU2634373C1 |
METHOD OF INCREASING PERFORMANCE LEVEL OF LABORATORY ANIMALS IN EXPERIMENT | 2015 |
|
RU2601393C1 |
METHOD OF WORK EFFICIENCY LEVEL INCREASE FOR LABORATORY ANIMALS IN EXPERIMENT | 2007 |
|
RU2371175C2 |
MEDICATION STIMULATING PHYSICAL ENDURANCE | 2010 |
|
RU2451508C2 |
METHOD OF TESTING PREPARATIONS WITH POTENTIAL PSYCOTROPIC OR ACT-PROTECTIVE ACTION | 2015 |
|
RU2601376C1 |
METHOD OF CORRECTING DISORDERS OF IMMUNE AND PSYCHOEMOTIONAL STATUS OF ORGANISM IN EXPERIMENTAL INFORMATION STRESS | 2010 |
|
RU2432949C1 |
PHARMACEUTICAL COMPOSITION BASED ON N-BUTYL-N-METHYL-1-PHENYLPYRROLO[1,2-a]PYRAZINE-3-CARBOXAMIDE | 2023 |
|
RU2811453C1 |
ANTIDEPRESSANT | 2012 |
|
RU2535027C2 |
DRUG POSSESSING ACTOPROTECTIVE, ANTIHYPOXIC, NEUROPROTECTIVE, ANTIAMNESTIC AND THERMOPROTECTIVE ACTIVITY | 2011 |
|
RU2460529C1 |
DRUG STABINORM FOR TREATING CHRONIC FATIGUE SYNDROME | 2008 |
|
RU2390348C1 |
Authors
Dates
2008-09-27—Published
2006-10-06—Filed